Partnering
Cellzome has entered into four partnerships with leading health care companies to date:
- Novartis: Our largest alliance, Cellzome's Proteomic Pathway Group and » NIBRI are identifying new drug targets and leads in a variety of disease areas by applying the Cellzome » pathway mapping and » chemical proteomics technologies.
- Ortho-McNeil Pharmaceutical / J & J PRD: Licensed Cellzome's » Alzheimer's disease program. The companies are now collaborating to advance the projects to clinical candidates.
- Bayer HealthCare: » Collaboration successfully completed.
- Johnson & Johnson PRD: » Collaboration successfully completed.
We also have links with several internationally recognized academic institutions, such as the European Molecular Biology Laboratory, the MIT, the Universities of Birmingham, Cologne, Edinburgh, Munich, Torino, Imperial College, and the Center for Molecular Medicine in Vienna.
Cellzome is interested in exploring strategic drug discovery collaborations based on its Kinobeads™ technology. For additional information and opportunities please contact business@cellzome.com